Merck MRK
NYSE MRK
$146.77 -0.36 (-0.24%)
At close: Sep 18, 2026 · 4:00 PM EDT

Merck (MRK) Other Operating Expenses (2010 - 2011)

Merck's (MRK) quarterly Other Operating Expenses came in at $500.0 million in Q1 2011, up 152.63% quarter-over-quarter from -$950.0 million in Q3 2010.

Analysis

Merck (MRK) Other Operating Expenses (2010 - 2011) Analysis & Trends

Merck (MRK) has reported Other Operating Expenses for 2 consecutive years, with $500.0 million the latest figure, recorded in Q1 2011.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $500.0 million in Q1 2011; TTM through Dec 2011 was $500.0 million, a 152.63% increase from a year earlier, with the FY2010 full-year figure at -$950.0 million, changed N/A from the prior year.
  • Other Operating Expenses was $500.0 million for Q1 2011 at Merck, up from -$950.0 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $500.0 million in Q1 2011 and troughed at -$950.0 million in Q3 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 500.00 Mn
Sep 30, 2010 -950.00 Mn